126 related articles for article (PubMed ID: 36921749)
1. Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients.
Zhao Y; Dhru U; Fleischmann E; Mostafa E; Al-Suqi M; Conaway MR; Krupnick AS; Linden J; Rabin J; Lau CL
Ann Thorac Surg; 2023 Dec; 116(6):1150-1158. PubMed ID: 36921749
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
[TBL] [Abstract][Full Text] [Related]
3. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor agonist (regadenoson) in human lung transplantation.
Lau CL; Beller JP; Boys JA; Zhao Y; Phillips J; Cosner M; Conaway MR; Petroni G; Charles EJ; Mehaffey JH; Mannem HC; Kron IL; Krupnick AS; Linden J
J Heart Lung Transplant; 2020 Jun; 39(6):563-570. PubMed ID: 32503727
[TBL] [Abstract][Full Text] [Related]
5. Chronic Alcohol Ingestion Impairs Rat Alveolar Macrophage Phagocytosis via Disruption of RAGE Signaling.
Staitieh BS; Egea EE; Fan X; Amah A; Guidot DM
Am J Med Sci; 2018 May; 355(5):497-505. PubMed ID: 29753380
[TBL] [Abstract][Full Text] [Related]
6. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
7. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
8. Lung inflammation biomarkers and lung function in children chronically exposed to arsenic.
Olivas-Calderón E; Recio-Vega R; Gandolfi AJ; Lantz RC; González-Cortes T; Gonzalez-De Alba C; Froines JR; Espinosa-Fematt JA
Toxicol Appl Pharmacol; 2015 Sep; 287(2):161-167. PubMed ID: 26048584
[TBL] [Abstract][Full Text] [Related]
9. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.
Antonelli A; Di Maggio S; Rejman J; Sanvito F; Rossi A; Catucci A; Gorzanelli A; Bragonzi A; Bianchi ME; Raucci A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):354-364. PubMed ID: 27913191
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
Chen YS; Wang XJ; Feng W; Hua KQ
Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
[TBL] [Abstract][Full Text] [Related]
13. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
[TBL] [Abstract][Full Text] [Related]
15. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
[TBL] [Abstract][Full Text] [Related]
17. The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.
Chhabra P; Linden J; Lobo P; Okusa MD; Brayman KL
Curr Diabetes Rev; 2012 Nov; 8(6):419-33. PubMed ID: 22934547
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
19. Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury.
Lenga Ma Bonda W; Fournet M; Zhai R; Lutz J; Blondonnet R; Bourgne C; Leclaire C; Saint-Béat C; Theilliere C; Belville C; Bouvier D; Blanchon L; Berger M; Sapin V; Jabaudon M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232959
[TBL] [Abstract][Full Text] [Related]
20. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
